ADAG
Adagene, Inc.
NASDAQ · Healthcare · Biotechnology · CN
$3.31
−1.78%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.10x
- Price / sales
- 23.86x
- Price / cash flow
- -11.52x
Enterprise value
- Enterprise value
- $117.0M
- EV / sales
- 12.56x
- EV / EBITDA
- -5.35x
- EV / EBIT
- -5.22x
- Market cap
- $222.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026